As Wall Street embarks on the first full week of August, the earnings wave continues with another stacked week of reports ...

Stocks tumbled from record highs on Friday as data revealed the US labor market is not on as solid footing as previously thought. On the week, the S&P 500 (^GSPC) fell nearly 2.4%, while the Nasdaq ...

Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.

With semaglutide patents set to expire in 2026, Indian pharma giants are ramping up peptide production and device tie-ups to ...

VHT is attractively valued at 16x forward earnings, but sector momentum is weak and technicals remain bearish. Read why VHT ...

The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...

President Donald Trump just sent letters to heads of 17 major pharmaceutical companies pushing them to drop drug prices in ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

Novo Nordisk has reported another significant criticality: the presence of unauthorized versions of its drugs on the US ...

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a ...

According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...